Regenxbio Inc (RGNX)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	85,585	89,565	82,833	89,765	89,470	395,745	424,505	432,813	446,605	134,740	275,433	273,347	271,089	261,412	95,283	71,153	44,415	73,424	54,848	86,998
Receivables	US$ in thousands	24,790	28,043	21,380	18,861	28,082	32,549	37,500	27,022	32,439	46,017	44,394	41,039	42,999	122,116	42,876	44,522	38,148	19,175	9,679	8,372
Receivables turnover		3.45	3.19	3.87	4.76	3.19	12.16	11.32	16.02	13.77	2.93	6.20	6.66	6.30	2.14	2.22	1.60	1.16	3.83	5.67	10.39

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $85,585K ÷ $24,790K
= 3.45

The receivables turnover ratio measures how efficiently a company is able to collect payments from its customers. Regenxbio Inc's receivables turnover has been fluctuating over the past eight quarters, ranging from a low of 3.54 to a high of 17.53.

In Q4 2023, the receivables turnover ratio was 3.64, indicating that Regenxbio Inc collected its outstanding receivables approximately 3.64 times during that quarter. Compared to the previous quarter, the turnover ratio slightly increased from 3.54. However, it is lower than the ratios recorded in the first two quarters of 2023, suggesting a potential slowdown in receivables collections efficiency.

Overall, the downward trend in receivables turnover from the high levels seen in Q2 and Q3 of 2022 to the more moderate levels in 2023 may indicate changing customer payment behaviors or collection practices by Regenxbio Inc. It is essential for the company to monitor this ratio closely to ensure efficient management of accounts receivable and timely collection of payments.